Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (4052)	6/7/2001 11:59:28 AM
From: IRWIN JAMES FRANKEL	Read Replies (2) \| Respond to of 52153

The story also supports MEDX which is rapidly ramping Mab production capacity. They also claim (can't prove it by me) that they have a superior means of producing Mab's and lots of experience in the area. ij

To: Biomaven who wrote (4052)	6/7/2001 12:04:27 PM
From: aknahow	Read Replies (1) \| Respond to of 52153

Peter, have heard that a large production facility was constructed and finished a year ago but has not obtained FDA validation. Anyone know which company might own this site and what the problems with validation are?

To: Biomaven who wrote (4052)	6/7/2001 5:04:59 PM
From: Jibacoa	Read Replies (2) \| Respond to of 52153

<<Pharmaceutical companies may have to become more actively involved in the production and manufacture of vital proteins, Arthur D. Little experts said. Arthur D. Little estimates that meeting industry cell-culture production requirements will demand more than $5 billion in capital.>> Do you think that has anything to do with NBSC going up 24.73% today ? <g> Although the volume was relatively small (32,000 shares) most of the "action" came in the late afternoon: 23,000 shares were traded in the last 2 hours with an uptick of 7,700 shares, (not mine <g>) at 3.55PM At any rate it closed at the H for the day with a B/A of 20/10 yahoo.marketguide.com siliconinvestor.com Bernard